Navigation Links
Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
Date:12/2/2010

with advanced HIV infection.

NEUPOGEN is contraindicated in patients with hypersensitivity to filgrastim or excipients. Not to be used for escalation of cytotoxic chemotherapy doses above established regimens or administered to patients with severe congenital neutropenia (Kostman's Syndrome) with abnormal cytogenetics.

Administer NEUPOGEN with caution in secondary AML. Safety and efficacy of NEUPOGEN not established in de novo AML patients < 55 years with good cytogenetics (t(8;21), t(15;17) and inv(16)). The onset of pulmonary signs (cough, fever, dyspnoea) in association with radiological signs of pulmonary infiltrates and deterioration in pulmonary function may be preliminary signs of Acute Respiratory Distress Syndrome (ARDS). Discontinue NEUPOGEN and give appropriate treatment.

Other adverse events of special importance associated with NEUPOGEN include GvHD and fatalities in patients receiving G-CSF after allogeneic bone marrow transplantation, very rare cases of splenic rupture reported in healthy donors and patients, and hypersensitivity-type reactions in cancer patients. NEUPOGEN should be permanently discontinued in patients who experience a serious allergic reaction. NEUPOGEN is not recommended in period 24 hours before to 24 hours after chemotherapy.  Neulasta is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Neulasta is contraindicated in patients with hypersensitivity to pegfilgrastim or excipients.

Neulasta should not be used in patients with MDS, CML and secondary AML. The safety and efficacy of Neulasta administration in de novo AML patients aged < 55 years with cytogenetics t(15;17) have not been established.

Neulasta should be discontinued following preliminary signs of
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Amgen Foundation and Ashokas Changemakers Announce Finalists in Patients
2. Choices
3. Empowerment Competition
4. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
5. Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LAs Promise
6. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
7. Amgen Announces Webcast of 2010 Third Quarter Financial Results
8. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
9. Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
10. Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
11. Amgen and Pfizer Introduce Psophisticated Style: A Guide to Everyday Style and Psoriasis™ Hosted by Tim Gunn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... CytRx Corporation (Nasdaq: CYTR ), ... today announced that study designs and progress from two ... pivotal global Phase 3 clinical trial in relapsed/refractory soft ... trial in small cell lung cancer, will be presented ... Congress being held September 26-30, in Madrid, ...
(Date:9/22/2014)... Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or ... based on the number of directly operated stores, today ... Shareholders (the "AGM") on October 22, 2014 at 10:00 a.m. Beijing ... the Company at 6th Floor, Tower B, Xinnengyuan Building, Nanhai Road, ... 518054, People,s Republic of China . ...
(Date:9/20/2014)... OTTAWA , Sept. 20, 2014 /CNW/ - The issue: ... voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered ... is part of the pump component. A ... delivery of nitroglycerin to the patient. This defect may lead ... fact they are unable to access it. Not receiving nitroglycerin ...
Breaking Medicine Technology:CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 2CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 5CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 6China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2
... ALEXANDRIA, Va., March 1, 2012  The National Community ... campaign launched today by the Pharmaceutical Care Management ... (PBMs). (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... said NCPA Senior Vice President for Government Affairs John ...
... PARSIPPANY, N.J., March 1, 2012  PDI, Inc. (Nasdaq: ... its fourth quarter and full year 2011 financial results ... and host a conference call on Thursday, March 8, ... information: ,  Date:Thursday, March 8, 2012Time:8:30 am Eastern timeDial-in ...
Cached Medicine Technology:NCPA Blasts Irresponsible Ad by PBM Lobby as an Affront to Fighting Drug Diversion, Pharmacy Crime 2NCPA Blasts Irresponsible Ad by PBM Lobby as an Affront to Fighting Drug Diversion, Pharmacy Crime 3
(Date:9/22/2014)... 22, 2014 Back pain is a daily ... idea of instant powerful pain relief without taking a dangerous ... in technology have made this very possible. Enter on-line retailer ... iReliev Tens Unit electronic back massager. This ... back pain relief each and every day, in a ...
(Date:9/22/2014)... California (PRWEB) September 22, 2014 Plugin ... of ProSparkle. A fully customizable 3D particle emitter made ... “Adding the ProSparkle particle emitter plugin to a video ... Christina Austin, CEO of Pixel Film Studios. “ProSparkle gives ... described as cool” , With ProSparkle users are given ...
(Date:9/22/2014)... Cleveland, Ohio (PRWEB) September 22, 2014 ... to announce its recognition by ERC as ... award honors Northeast Ohio’s best places to work for ... their ability to build and maintain great workplaces that ... Areas which are evaluated include staffing and workforce, development ...
(Date:9/22/2014)... A Case Management Order (CMO) was issued on ... for testosterone lawsuit claims pending in multidistrict litigation in ... Wright & Schulte LLC notes the CMO, parties ... about potential witnesses and documents in testosterone therapy lawsuits. ... topics in Plaintiff Fact Sheets before another status conference ...
(Date:9/22/2014)... September 22, 2014 Reflecting their position ... iron products, Strictly Doors and Gates is now ... reasonable prices. The company offers quality wrought iron ornamental ... They have a versatile range of ornamental doors that ... will also get custom-made ornamental doors wherein their specifications ...
Breaking Medicine News(10 mins):Health News:Online Retailer Variety4Kicks Announces An Over The Counter Tens Unit For Back Pain Relief Is Now Available For Sale 2Health News:Announcing a new ProSparkle Particle Emitter Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:The Center for Health Affairs Named to 2014 NorthCoast 99 List 2Health News:The Center for Health Affairs Named to 2014 NorthCoast 99 List 3Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 2Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 3Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 4Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 5Health News:Strictly Doors and Gates Now Adding Ornamental Iron Gates to Their Products Line 2
... 6, GlaxoSmithKline (NYSE: GSK ) announced today ... Inc. (Sirtris),for approximately USD720 million (or approx. GBP362 ... USD22.50 (or approx. GBP11.33) per share., Through ... its,metabolic, neurology, immunology and inflammation research efforts by,establishing ...
... led by Professor Makoto Tominaga and Research Assistant Professor ... found that a sour taste receptor, PKD1L3-PKD2L1 channel complex, ... only after the removal of acid stimulus. They call ... taste receptor. They reports their finding in an international ...
... HOUSTON, June 6 Carriage Services, Inc.,(NYSE: ... its "Company & Investment,Profile", which can be found ... updated Company & Investment Profile includes updated,discussions of ... financial outlook and more., The Company & ...
... TreAura, Reminder Service, Edge Health Solutions brings Medicine 2.0 to ... ... RICHMOND, British Columbia, June 5 Edge Health,Solutions, innovators of medical ... Mac OS X, announces the,release of edgeMD 2.0(TM) and edgeDMS 2.0(TM). ...
... CHICAGO, June 5 In a June 5 joint ... America (ELCA) and,the Episcopal Church urged U.S. citizens to ... action" from the international community to restore,stability there., ... the Rev. Katharine Jefferts,Schori of the Episcopal Church made ...
... nearly halved in Dutch study , , THURSDAY, June 5 (HealthDay ... treatment of a heart attack reduced the one-year death rate ... cardiologists said could change medical practice. , The latest data ... that just 19 of 535 heart attack victims -- 3.6 ...
Cached Medicine News:Health News:Carriage Services Updates Company & Investment Profile 2Health News:Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization 2Health News:Lutheran, Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 2Health News:Sucking Out Clot Debris Helps Heart Attack Patients 2Health News:Sucking Out Clot Debris Helps Heart Attack Patients 3
... Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope provides a new ... The latest in Fujinon engineering combines ... guide, and a wide 90 degree field ... distal tip diameter. In addition, the ...
... Tip Laryngoscopes are the most ... The articulating tip aids during ... improved view of epiglottis. Available ... styles. We guarantee your complete ...
German Style MacIntosh Fiber Optic Blade Laryngoscopes...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: